Prevalence and correlates of elevated serum creatinine levels: The Framingham Heart Study

Archives of Internal Medicine

Volumn 159, Issue 15, 1999, Pages 1785-1790

  Culleton, Bruce F ^a   Larson, Martin G ^a,b   Evans, Jane C ^a,b   Wilson, Peter W F ^a   Barrett, Brendan J ^c   Parfrey, Patrick S ^c   Levy, Daniel ^a  

^a FRAMINGHAM HEART STUDY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Framingham Heart Study ^*

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ADULT; AGE DISTRIBUTION; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY MASS; COMORBIDITY; CORRELATION FUNCTION; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE;

ADULT; AGE FACTORS; AGED; CARDIOVASCULAR DISEASES; CREATININE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DISEASE PROGRESSION; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LOGISTIC MODELS; MALE; MASSACHUSETTS; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK FACTORS;

EID: 0033598089     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.159.15.1785     Document Type: Article

References (45)

1. Canadian Institute for Health Information. Annual Report 1996, Volume 1: Dialysis and Renal Transplantation. Ottawa, Ontario: Canadian Organ Replacement Register, Canadian Institute for Health Information; 1996.
2. National Institute of Diabetes and Digestive and Kidney Diseases, U.S. Renal Data System, 1997Annual Data Report. Bethesda, Md: National Institutes of Health; 1997.
3. Levey AS, Perrone RD, Madias NE. Serum creatinine and renal function. Annu Rev Med. 1988;39:465-490.
4. Iseki K, Ikemiya Y, Fukiyama K. Risk factors of end-stage renal disease and serum creatinine in a community-based mass screening. Kidney Int. 1997;51:850-854.
5. Iseki K, lkemiya Y, Fukiyama K. Blood pressure and risk of end-stage renal disease in a screened cohort. Kidney Int Suppl. 1996;55:S69-S71.
6. Iseki K, Iseki C, Ikemiya Y, Fukiyama K. Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int. 1996;49:800-805.
7. Klag MJ, Whelton PK, Randall BL, et al. Blood pressure and end-stage renal disease in men. N Engl J Med. 1996;334:13-18.
8. Perneger TV, Nieto FJ, Whelton PK, Klag MJ, Cornstock GW, Szklo M. A prospective study of blood pressure and serum creatinine: results from the 'Clue' Study and the ARIC Study. JAMA. 1993;269:488-493.
9. Salive ME, Jones CA, Guralnik JM, Agodoa LY, Pahor M, Wallace RB. Serum creatinine levels in older adults: relationship with health status and medications. Age Ageing. 1995;24:142-150.
10. Feinfeld DA, Guzik H, Carvounis CP, et al. Sequential changes in renal function tests in the old old: results from the Bronx Longitudinal Aging Study. JAm Geriatr Soc. 1995;43:412-414.
11. Dawber TR, Meadors GF, Moore FE. Epidemiologic approaches to heart disease: the Framingham Heart Study. Am J Public Health. 1951;41:279-286,
12. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP. An investigation of coronary heart disease in families: the Framingham Offspring Study. Am J Epidemiol. 1979;110:281-290.
13. Bowers LD, Wong ET. Kinetic serum creatinine assays, II: a critical evaluation and review. Clin Chem. 1980;26:555-561.
14. Bowers LD. Kinetic serum creatinine assays, I: the role of various factors in determining specificity. Clin Chem. 1980;26:551-554.
15. Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem. 1992;38:1933-1953.
16. Shurtleff D. Some characteristics related to the incidence of cardiovascular disease and death: Framingham Heart Study 18-year follow-up. In: Kannel WB, Gordon T, eds. The Framingham Study, Section 30. Washington, DC: US Government Printing Office: 1974:17-25.
17. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and National High Blood Pressure Education Program Coordinating Commitee. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413-2446.
18. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley & Sons Inc; 1989.
19. National Institutes of Health. Health implications of obesity: National Institutes of Health Consensus Development Conference Statement. Ann Intern Med. 1985; 103:147-151.
20. SAS/STAT Software: Changes and Enhancements Through Release 6.11. Cary, NC: SAS Institute Inc; 1996:383-490.
21. Disney AP. ANZDATA Report. Adelaide, South Australia: Australia and New Zealand Dialysis and Transplant Registry; 1996.
22. European Dialysis and Transplant Association. Report on management of renal failure in Europe, XXIII, 1992. Nephrol Dial Transplant. 1994;9(suppl 1):6-25.
23. Jungers P, Chauveau P, Descamps-Latscha B, et al. Age and gender-related incidence of chronic renal failure in a French urban area: a prospective epidemiologic study. Nephrol Dial Transplant. 1996;11:1542-1546.
24. Khan IH, Catto GR, Edward N, MacLeod AM. Chronic renal failure: factors influencing nephrology referral. QJM. 1994;87:559-564.
25. Strauss MJ, Port FK, Somen C, Wolfe RA. An estimate of the size of the US predialysis population with renal insufficiency and anemia. Am J Kidney Dis. 1993; 21:264-269.
26. McGeown MG. Prevalence of advanced renal failure in Northern Ireland. BMJ. 1990;301:900-903.
27. Cohn SH, Vartsky D, Yasumura S, et al. Compartmental body composition based on total-body nitrogen, potassium, and calcium. Am J Physiol. 1980;239:E524-E530.
28. Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc. 1985;33:278-285.
29. Rowe JW, Andres R, Tobin JD, Norris AH, Shock NW. The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. J Gerontol. 1976;31:155-163.
30. Rowe JW, Andres R, Tobin JD. Age-adjusted standards for creatinine clearance. Ann Intern Med. 1976;84:567-569.
31. Wald H. The weight of normal adult human kidneys and its variability. Arch Pathol Lab Med. 1937;23:493-500.
32. Kaplan C, Pastemack B, Shah H, Gallo G. Age-related incidence of sclerotic glomeruli in human kidneys. Am J Pathol. 1975;80:227-234.
33. Kappel B, Olsen S. Cortical interstitial tissue and sclerosed glomeruli in the normal human kidney, related to age and sex: a quantitative study. Virchows Arch Pathol Anat, 1980;387:271-277.
34. Greger R, Heidland A. Action and clinical use of diuretics. In: Cameron JS, Davison AM, Grunfeld JP, eds. Clinical Nephrology. London, England: Oxford University; 1991:197.
35. Favre L, Glasson P, Vallotton MB. Reversible acute renal failure from combined triamterene and indomethacin: a study in healthy subjects. Ann Intern Med. 1982; 96:317-320.
36. Raal FJ, Kalk WJ, Taylor DR, Osier CE, Panz VR. The relationship between the development and progression of microalbuminuria and arterial blood pressure in type 1 (insulin-dependent) diabetes mellitus. Diabetes Res Clin Pract. 1992; 16:221-227.
37. Mathiesen ER, Ronn B, Jensen T, Storm B, Deckert T. Relationship between blood pressure and urinary albumin excretion in development of microalbuminuria. Diabetes. 1990;39:245-249.
38. Nelson RG, Pettitt DJ, Baird HR, et al. Pre-diabetic blood pressure predicts urinary albumin excretion after the onset of type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians. Diabetologia. 1993;36:998-1001.
39. Barzilay J, Warram JH, Bak M, Laffel LM, Canessa M, Krolewski AS. Predisposition to hypertension: risk factor for nephropathy and hypertension in IDDM. Kidney Int. 1992;41:723-730.
40. Krolewski AS, Canessa M, Warram JH, et al. Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med. 1988;318:140-145.
41. Viberti GC, Keen H, Wiseman MJ. Raised arterial pressure in parents of proteinuric insulin-dependent diabetics. BMJ. 1987;295:515-517.
42. Baumgartner RN, Heymsfield SB, Roche AF. Human body composition and the epidemiology of chronic disease. Obes Res. 1995;3:73-95.
43. Boorsook H, Bubroff JW. The hydrolysis of phosphocreatine and the origin of urinary creatinine. J Biol Chem. 1947;168:493-510.
44. Morbidity and Mortality: 1996 Chartbook on Cardiovascular, Lung, and Blood Diseases. Bethesda, Md: National Institutes of Health; 1996.
45. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.